Lantern Pharma shareholders elect six directors and ratify auditor at 2022 annual meeting

Lantern Pharma Inc.

All six director nominees elected: Keyser, Sharma, Chandru, Maccecchini, Prendergast, Silberstein.
EisnerAmper LLP ratified as independent auditor for FY 2022 with 7.48M shares for, 18,585 against.
Director votes ranged from 3.85M to 3.85M for; broker non-votes of 3.67M on each director election.
No broker non-votes on auditor ratification.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.